Research fellow

Dr. Tania Schink

Curriculum vitae

  • since April 2010 Head of "Drug Safety" unit
  • since February 2009 Research Associate at the Leibniz Institute for Prevention Research and Epidemiology - BIPS
  • June 2007 Doctorate in Medical Sciences, Charité, Humboldt University Berlin
  • November 2007 Master of Public Health, Harvard School of Public Health, Boston, USA; Concentration: Quantitative Methods (Epidemiology & Pharmacoepidemiology), Focus: Decision Sciences
  • March 2001 - February 2008 Research Associate at the Department of Biostatistics and Clinical Epidemiology at the Charité, Universitätsmedizin Berlin
  • January 2000 - December 2000 Research Associate at the Department of Medical Computer Sciences, Biostatistics and Epidemiology at the Ludwig-Maximilians-Universität, München
  • November 1999 Diplom in Statistics, Ludwig-Maximilians-University, Munich

Research interests

  • Drug and vaccine safety, esp. during pregnancy
  • Administrative databases



Selected publications

  • Articles with peer-review

  • Masclee G, Straatman H, Arfè A, Castellsagué J, Garbe E, Herings R, Kollhorst B, Lucchi S, Perez-Gutthan S, Romio S, Schink T, Schumie MJ, Scotti L, Varas-Lorenzo C, Valkhoff VE, Villa M, Schade R, Sturkenboom MCJM. Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project. PLOS ONE. 2018;13(11):e0204746.
  • Schink T, Kollhorst B, Varas-Lorenzo C, Arfè A, Herings R, Lucchi S, Romio S, Schade R, Schuemie M, Straatman H, Valkhoff VE, Villa M, Sturkenboom MCJM, Garbe E. Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project. PLOS ONE. 2018;13(9):e0203362.
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Valproatverordnungen bei Mädchen und Frauen im gebärfähigen Alter in Deutschland: Untersuchung zeitlicher Trends basierend auf Versichertendaten. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2018;61(8):1022-1029.
  • Wentzell N, Schink T, Haug U, Ulrich S, Niemeyer M, Mikolajczyk R. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data. Pharmacoepidemiology and Drug Safety. 2018;27(9):1005-1010.
  • Czwikla J, Jobski K, Schink T. The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data. BMC Medical Research Methodology. 2017;17:122.
  • Jobski K, Kollhorst B, Garbe E, Schink T. The risk of ischemic cardio- and cerebrovascular events associated with oxycodone-naloxone and other extended-release high-potency opioids: A nested case-control study. Drug Safety. 2017;40(6):505-515.
  • Jobski K, Schmedt N, Kollhorst B, Krappweis J, Schink T, Garbe E. Characteristics and drug use patterns of older antidepressant initiators in Germany. European Journal of Clinical Pharmacology. 2017;73(1):105-113.
  • La Gamba F, Corrao G, Romio S, Sturkenboom MCJM, Trifirò G, Schink T, de Ridder M. Combining evidence from multiple electronic health care databases: Performances of one-stage and two-stage meta-analysis in matched case-control studies. Pharmacoepidemiology and Drug Safety. 2017;26(10):1213-1219.
  • Poluzzi E, Diemberger I, de Ridder M, Koci A, Clò M, Oteri A, Pecchioli S, Bezemer I, Schink T, Ulrichsen SP, Boriani G, Sturkenboom MCJM, De Ponti F, Trifirò G. Use of antihistamines and risk of ventricular tachyarrhythmia: A nested case-control study in five European countries from the ARITMO project. European Journal of Clinical Pharmacology. 2017;73(11):1499-1510.
  • Thöne K, Kollhorst B, Schink T. Non-steroidal anti-inflammatory drug use and the risk of acute myocardial infarction in the general German population: A nested case-control study. Drugs - Real World Outcomes. 2017;4(3):127-137.
  • Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM. Use of azithromycin and risk of ventricular arrhythmia. Canadian Medical Association Journal. 2017;189(15):E560-E568.
  • Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff VE, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom MCJM, Corrao G, on behalf of the SOS project consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: Nested case-control study. The BMJ. 2016;354:i4857.
  • Douros A, Jobski K, Kollhorst B, Schink T, Garbe E. Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions. British Journal of Clinical Pharmacology. 2016;82(3):839-848.
  • Schink T, Behr S, Thöne K, Bricout H, Garbe E. Risk of stroke after herpes zoster - Evidence from a German self-controlled case-series study. PLOS ONE. 2016;11(11):e0166554.
  • Schmedt N, Jobski K, Kollhorst B, Krappweis J, Schink T, Rüther E, Garbe E. Treatment patterns and characteristics of older antipsychotic users in Germany. International Clinical Psychopharmacology. 2016;31(3):159-169.
  • Schmedt N, Kollhorst B, Enders D, Jobski K, Krappweis J, Garbe E, Schink T. Comparative risk of death in older adults treated with antipsychotics: A population-based cohort study. European Neuropsychopharmacology. 2016;26(9):1390-1400.
  • Swart E, Bitzer EM, Gothe H, Harling M, Hoffmann F, Horenkamp-Sonntag D, Maier B, March S, Petzold T, Röhrig R, Rommel A, Schink T, Wagner C, Wobbe S, Schmitt JM. STandardisierte BerichtsROutine für Sekundärdaten Analysen (STROSA) - ein konsentierter Berichtsstandard für Deutschland, Version 2. Das Gesundheitswesen. 2016;78(Suppl. 1):e145-e160.
  • Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine. 2014;32(6):645-650.
  • Book chapters

  • Fröhlich N, Schink T. Aclidinium- oder Tiotropiumbromid? Untersuchung von Prädiktoren einer Aclidiniumbromidneuverordnung auf Basis von Routinedaten der DAK-Gesundheit. In: Rebscher H, editor. AMNOG-Report 2016. Nutzenbewertung von Arzneimitteln in Deutschland. Heidelberg: medhochzwei. 2016. S. 223-236.

For further publications please follow this link:

The responsibility for the content of this page lies with Tania Schink.